14:1 EPC trifluoromethanesulfonate

Cat. No.: HY-144015: Fiche technique Instruction de manipulation
FAQs
Technical Support

14:1 EPC trifluoromethanesulfonate is ethyl-phosphatidylcholine (EPC) with monounsaturated 14:1 chains. 14:1 EPC trifluoromethanesulfonate shows transfection activity. 14:1 EPC trifluoromethanesulfonate can be used for drug delivery.

Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.

14:1 EPC trifluoromethanesulfonate Chemical Structure

CAS No. : 1246304-44-8

Size	Stock	Quantité
1 mg	Obtenir un devis 3 - 4 Weeks 4 - 5 Weeks 5 - 6 Weeks 2 - 3 weeks	Estimated Time of Arrival: December 31
5 mg	Obtenir un devis 3 - 4 Weeks 4 - 5 Weeks 5 - 6 Weeks 2 - 3 weeks	Estimated Time of Arrival: December 31
10 mg	Obtenir un devis 3 - 4 Weeks 4 - 5 Weeks 5 - 6 Weeks 2 - 3 weeks	Estimated Time of Arrival: December 31
50 mg	Obtenir un devis
100 mg	Obtenir un devis

Synthetic products have potential research and development risk.

or Bulk Inquiry

* Veuillez sélectionner la quantité avant d'ajouter des articles.

This product is a controlled substance and not for sale in your territory.

Avis client

Based on 1 Customer Validation

Recommandations en vedette

•Related Screening Libraries:

•Related Small Molecules:

•Related Proteins:

Activité biologique
Pureté et documentation
Références
Avis client

Description	14:1 EPC trifluoromethanesulfonate is ethyl-phosphatidylcholine (EPC) with monounsaturated 14:1 chains. 14:1 EPC trifluoromethanesulfonate shows transfection activity. 14:1 EPC trifluoromethanesulfonate can be used for drug delivery^[1]^[2].
Masse moléculaire	852.03
Formule	C₃₉H₇₃F₃NO₁₁PS
CAS No.	1246304-44-8
SMILES	O=S(C(F)(F)F)([O-])=O.C[N+](C)(C)CCOP(OC[C@@H](COC(CCCCCCC/C=C\CCCC)=O)OC(CCCCCCC/C=C\CCCC)=O)(OCC)=O
Livraison	Room temperature in continental US; may vary elsewhere.
Stockage	Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation	Fiche technique (261 KB) Instruction de manipulation (2659 KB)
Références	[1]. Koynova R, et al. Enhancing nucleic acid delivery, insights from the cationic phospholipid carriers. Curr Pharm Biotechnol. 2014;15(9):806-13. [Content Brief] [2]. Koynova R, et al. Hydrophobic moiety of cationic lipids strongly modulates their transfection activity. Mol Pharm. 2009 May-Jun;6(3):951-8. [Content Brief]